Skip to the page

Data / Form D filings / Oculogica, Inc.

Oculogica, Inc.: Form D filings

Oculogica, Inc., a biotechnology company in New Richmond, WI, filed 5 Form D notices with the SEC between 2014 and 2024. The latest, on May 13, 2024, reports $7.6 million sold of a $18 million offering to 24 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1477 S. Knowles Ave. #110F, New Richmond, WI, 54017
Phone
(484) 393-2694
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1613810

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 13, 2024New notice$17,952,926$7,569,130$10,383,79624Apr 26, 2024sec.gov
Jun 23, 2022New notice$4,500,000$4,048,963$451,03720Mar 18, 2022sec.gov
Jan 3, 2020New notice$8,571,753$8,071,764$499,98941Dec 17, 2019sec.gov
Mar 17, 2016New notice$2,500,000$1,689,998$810,0028Mar 4, 2016sec.gov
Jul 16, 2014New notice$999,999$599,970$400,0296May 20, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jim FlanniganDirector
Kathryn SwintekDirector
Rosina SamadaniExecutive Officer, Director
Pratipatti LaxminarainDirector
Jill EnosDirector
Uzma SamadaniDirector

Every Form D from the week of May 13, 2024 · All recent filings in Wisconsin · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Oculogica, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.